Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story Anthony Mthembu | Photo Supplied
Prof Tameshnie Deane
Prof Tameshnie Deane, Vice-Dean: Research, Postgraduate Studies and Internationalisation in the Faculty of Law at the University of the Free State (UFS).

The Faculty of Law at the University of the Free State (UFS) has appointed Prof Tameshnie Deane as Vice-Dean: Research, Postgraduate Studies and Internationalisation. Prof Deane officially assumed this role on 1 July 2024, following over two decades as a Professor and Head of the Criminal Law Unit at the University of South Africa (UNISA).

Prof Deane, who has approached this new position with great enthusiasm, describes it as a significant opportunity. ‘’This role allows me to influence the future of academic research and postgraduate education at UFS,’’ she said.

Support for postgraduate students

Prof Deane elaborated on her vision, saying, “My aim is to develop and implement strategies that elevate the quality and impact of research, foster innovation, and support postgraduate students in achieving their academic and professional goals.”

Among her top priorities is strengthening support for postgraduate students at the UFS. “I plan to introduce comprehensive mentorship programmes where experienced faculty members guide students through their academic and research journeys. We will offer training in key skills such as legal writing, research methodologies, and public speaking, while also prioritising initiatives to support their mental and emotional well-being,’’ she explained.

Prof Deane emphasised that creating a dynamic and supportive environment will contribute to academic excellence and personal growth for postgraduate students at the UFS.

Enhancing internationalisation and strategic collaborations

Prof Deane is also committed to advancing the internationalisation of the Faculty of Law.  “We aim to provide opportunities for international collaboration and exchange, which will broaden the scope and impact of our research and postgraduate programmes,’’ she said.

Improving research quality and output remains a core objective, with Prof Deane identifying this as central to her new role.

One of the initiatives Prof Deane is eager to lead is the development of strategic partnerships with industry and academic institutions. “Collaborations like these will provide invaluable resources for research projects,” she noted.

To foster these partnerships, Prof Deane plans to leverage technology to strengthen communication and collaboration, support relationship-building events, and promote interdisciplinary projects that encourage diverse perspectives and innovative solutions. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept